Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
DE000A3H2101
Mon, 30.10.2023
aap Implantate AG
Clinical trial: Visible acceleration with already more than 60 patients recruited since clinical trial resumption in April; completion of patient recruitment planned in 2024
BMBF funding: increase in total funding by around EUR 0.4 million to up to EUR 3.1 million underscores the strategic innovative character of aap's antibacterial silver coat [ … ]
Thu, 31.08.2023
aap Implantate AG
aap Implantate AG ("aap" or the "Company") announces that Mr. Jochen Rahner will succeed CFO Mr. Marek Hahn as Director Finance, IR and IT as of November 1, 2023. Mr. Rahner has over 20 years of financial experience in various functions and holds a degree in mechanical engineering. We are convinced that Mr. Rahner will confidently lead the areas of [ … ]
Mon, 14.08.2023
aap Implantate AG
Sales: Q2 at EUR 2.9 million (+8 % yoy) and H1 at EUR 5.9 million (+6 % yoy); all regions in Q2 above previous year with LATAM (Q2: +13 %; H1: +29 % yoy) and North America (Q2: +7 %; H1: +11 % yoy) as main growth drivers
EBITDA: improvement in Q2 (+21 %) with EUR ‑0.6 million (Q2/2022 corr.: EUR ‑0.7 million) and H1 (+13 %) with EUR ‑1.0 millio [ … ]
Thu, 27.07.2023
aap Implantate AG
aap shareholders met for the Annual General Meeting in Berlin on July 25, 2023
Around 63 percent of the capital stock was represented at the Annual General Meeting
All items on the agenda were approved with approval rates of >99 %
aap Implantate AG ("aap" or the "Company") had invited its shareholders to the Annual General Meeting on July [ … ]
Thu, 27.07.2023
aap Implantate AG
aap shareholders met for the Annual General Meeting in Berlin on July 25, 2023
Around 63 percent of the capital stock was represented at the Annual General Meeting
All items on the agenda were approved with approval rates of >99 %
aap Implantate AG ("aap" or the "Company") had invited its shareholders to the Annual General Meeting on July [ … ]
Thu, 20.07.2023
aap Implantate AG
With regard to its innovative antibacterial silver coating technology, aap was able to successfully resume recruitment in the ongoing human clinical trial with an adapted study design and achieve a significant acceleration in patient recruitment after only a short time with the new study protocol.
Currently, aap expects patient recruitment to be [ … ]
Thu, 20.07.2023
aap Implantate AG
With regard to its innovative antibacterial silver coating technology, aap was able to successfully resume recruitment in the ongoing human clinical trial with an adapted study design and achieve a significant acceleration in patient recruitment after only a short time with the new study protocol.
Currently, aap expects patient recruitment to be [ … ]
Tue, 18.07.2023
aap Implantate AG
Sales Q2: EUR 2.9 million (+8 % yoy); LATAM (+13 % yoy), USA (+7 % yoy) and EMEA (+6 % yoy, resulting from growth in Germany).
Revenue half-year 2023: EUR 5.9 million (+6 % yoy); LATAM (+29 % yoy) and USA (+11 % yoy) with significant double-digit growth; EMEA at -3 % yoy, recovery trend after Q1 due to upturn in Q2.
aap Implantate AG ("aap" or th [ … ]
Tue, 18.07.2023
aap Implantate AG
Sales Q2: EUR 2.9 million (+8 % yoy); LATAM (+13 % yoy), USA (+7 % yoy) and EMEA (+6 % yoy, resulting from growth in Germany).
Revenue half-year 2023: EUR 5.9 million (+6 % yoy); LATAM (+29 % yoy) and USA (+11 % yoy) with significant double-digit growth; EMEA at -3 % yoy, recovery trend after Q1 due to upturn in Q2.
aap Implantate AG ("aap" or th [ … ]
Wed, 14.06.2023
aap Implantate AG
The Management Board and Supervisory Board of aap Implantate AG ("aap" or the "Company") have, in the run-up to the adoption of the notice convening the Annual General Meeting to be held on July 25, 2023, intensively considered the Company's situation, its future development and the current and assumed macroeconomic environment in the further cours [ … ]